Skip to content
10-Q

Quarterly Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-21-001974

← back to feed
Filed
Aug 19, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 13, 2021 160.79M sh
Current Liabilities Q2 2020 · Jun 30, 2020 $9.94M
Current Liabilities Q2 2020 · Dec 31, 2019 $9.97M
Total Liabilities Q2 2020 · Jun 30, 2020 $9.94M
Total Liabilities Q2 2020 · Dec 31, 2019 $9.97M
Current Assets Q2 2020 · Jun 30, 2020 $117.61K
Current Assets Q2 2020 · Dec 31, 2019 $98.96K
Total Assets Q2 2020 · Jun 30, 2020 $2.95M
Total Assets Q2 2020 · Dec 31, 2019 $3.06M
Shares Diluted Q2 2020 · Jun 30, 2019 160.79M sh
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$43.32K
Stockholders Equity Q2 2020 · Jun 30, 2019 −$6.61M
Stockholders Equity Q2 2020 · Mar 31, 2019 −$6.49M
Stockholders Equity Q2 2020 · Dec 31, 2018 −$6.41M
Net Income Q2 2020 · Jun 30, 2019 −$123.49K
Net Income Q2 2020 · Mar 31, 2019 −$75.69K
Operating Income Q2 2020 · Jun 30, 2019 −$151.47K
Operating Income Q2 2020 · Jun 30, 2019 −$249.66K
Gross Profit Q2 2020 · Jun 30, 2019 $6.21K
Gross Profit Q2 2020 · Jun 30, 2019 $7.04K
Revenue Q2 2020 · Jun 30, 2019 $41.44K
Revenue Q2 2020 · Jun 30, 2019 $71.28K